A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis patients showed that the therapy was safe and dramatically reduced patients’ immune systems’ reactivity to myelin by 50 to 75 percent, according to new Northwestern Medicine® research.
The third annual event co-sponsored by neurology and the Les Turner ALS Foundation brought together scientists, students, and guests to learn more about the molecular link between two often disconnected fields of study.
Susan Quaggin, MD, chief of the Division of Nephrology, has been given the Alfred Newton Richards Award from the International Society of Nephrology for basic science research in the field. The honor was presented June 2 in Hong Kong during the World Congress of Nephrology, the leading biennial educational event in international nephrology.
Addie Boone, a second-year medical student, received one of 31 Schweitzer Fellowships, which support public health research. She will use the award to develop a partnership between the medical school, Northwestern University Law School, and community clinics to help underserved patients with poorly-controlled asthma encourage their landlords to comply with habitability laws.
Leon Epstein, MD, and Phyllis Zee, MD, have published an editorial in JAMA linking sleep cycles, migraine headaches, and colic in infants.
A collaborative study using semi-structured interviews with black, white, and Hispanic women found that among the factors deterring lifestyle changes are lack of time and fatigue associated with motherhood.
Seventeen awards were presented to students and faculty at the inaugural event on May 22. Gaurava Agarwal, MD, instructor in psychiatry and behavioral sciences, was honored as its first keynote speaker.
A leader in the field of antipsychotic drugs, Herbert Meltzer, MD, professor in psychiatry and behavioral sciences, has published an update on their use in the Annual Review of Medicine.
Members of the Physician Assistant Program earned Master of Medical Science degrees on May 18.
Northwestern University has established a major new initiative – the Developmental Therapeutics Institute – with an initial $10 million investment that will bring more early-stage clinical studies of new anti-cancer approaches to Chicago. This program will also develop much needed new therapies for cancer and other diseases based on Northwestern’s preclinical and translational research by…
Notifications